ArticleKidney international reports2018
Mortality in Patients With Chronic Renal Disease Without Health Insurance in Mexico: Opportunities for a National Renal Health Policy.
Article in Kidney international reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 40 citations in OpenAlex.
- Kidney Function and Mortality in Mexico: Prospective Study of 130,000 Adults.Kidney medicine · 2026Article
- Implementation of the AAMATES Platform as a National Registry for Stage 5 CKD in Mexico.Kidney medicine · 2026Article
- Mortality and Practice Patterns in the MEXHEMO Hemodialysis Cohort.Kidney international reports · 2026Article
- [Social security burden due to work-related disability due to kidney failure].Revista medica del Instituto Mexicano del Seguro Social · 2026Observational
- Out-of-pocket healthcare expenditures in older Mexican people based on their social security status.Health policy and planning · 2026Article
- Outcomes of Initiating Peritoneal Dialysis versus Hemodialysis in Severe, Symptomatic Kidney Failure.Kidney360 · 2025Article
- Perceptions of COVID-19 patients in the use of bioethical principles and the physician-patient relationship: a qualitative approach.BMC medical ethics · 2024Article
- Chronic kidney disease acquired knowledge in a diabetic and hypertensive population using a translated and validated questionnaire.Renal failure · 2023Observational
- Association between the changes in socialsecurity continuity condition and mortality: MHAS 2001-2018 analysis.Salud publica de Mexico · 2023Article
- Estimation of vaccination coverage and associated factors in older Mexican adults.Epidemiology and infection · 2023Article
- Evaluation of hemodialysis vascular access. Perspective from Mexico.Frontiers in nephrology · 2023Article
- Health Needs Assessment: Chronic Kidney Disease Secondary to Type 2 Diabetes Mellitus in a Population without Social Security, Mexico 2016-2032.International journal of environmental research and public health · 2022Article
- Update on Existing Care Models for Chronic Kidney Disease in Low- and Middle-Income Countries: A Systematic Review.Canadian journal of kidney health and disease · 2022Article
- An Empirical Study on the Influence of the Basic Medical Insurance for Urban and Rural Residents on Family Financial Asset Allocation.Frontiers in public health · 2021Article
- Current State of Diabetes Mellitus Prevalence, Awareness, Treatment, and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across the Continent.Current diabetes reports · 2020Review
- Association between Serum Uric Acid Levels, Nutritional and Antioxidant Status in Patients on Hemodialysis.Nutrients · 2020Article
- Global Dialysis Perspective: Mexico.Kidney360 · 2020Article
- Health care trajectories and barriers to treatment for patients with end-stage renal disease without health insurance in Mexico: a mixed methods approach.International journal for equity in health · 2020Article
- Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017.BMJ open · 2020Article
- The Tragedy of Having ESRD in Mexico.Kidney international reports · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDespite a systematic increase in the coverage of patients with end-stage renal disease (ESRD) who have received dialytic therapies and transplantation over the past 2 decades, the Mexican health system currently still does not have a program to provide full coverage of ESRD. Our aim was to analyze mortality in patients with ESRD without health insurance.
methodsThis was a prospective cohort study of 850 patients with advanced chronic kidney disease (CKD). Risk factors associated with death were calculated using a Cox's proportional hazards model. We used the statistical package SPSS version 22.0 for data analysis.
resultsThe mean age of patients was 44.8 ± 17.2 years old. At the time of hospital admission, 87.6% of the population did not have a social security program to cover the cost of renal replacement treatment, and 91.3% of families had an income below US$300 per month. During the 3 years of the study, 28.8% of the cohort patients were enrolled in 1 of Mexico's social security programs. The 3-year mortality rate was of 56.7% among patients without access to health insurance, in contrast to 38.2% of patients who had access to a social security program that provided access to renal replacement therapy (
conclusionMexico needs a coordinated National Kidney Health and Treatment Program. A program of this nature should provide the basis for an appropriate educational and intervention strategy for early detection, prevention, and treatment of patients with advanced chronic kidney disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.